Do Patients With Diabetes Have Poorer Improvements in Patient-Reported Outcomes After Total Knee Arthroplasty?

Siyuan Zhang,Mark Chong,Bernard Puang Huh Lau,Yau Hong Ng,Xinyu Wang,Weiliang Chua
DOI: https://doi.org/10.1016/j.arth.2021.02.070
IF: 4.435
2021-07-01
The Journal of Arthroplasty
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>Diabetes is one of the most common comorbidities in patients undergoing Total Knee Arthroplasty (TKA) for osteoarthritis. However, the evidence remains unclear on how it affects patient reported outcome measures (PROMs) after TKA.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>We reviewed prospectively collected data of 2840 patients who underwent primary unilateral TKA between 2008 and 2018, of which 716 (25.2%) had diabetes. All patients had their HbA1c measured within 1 month before surgery and only well-controlled diabetics (HbA1c &lt;8.0%) were allowed to proceed with surgery. Patient demographic and comorbidities were recorded, and multiple regression was performed to evaluate the impact of diabetes on improvements in PROMs (SF-36, WOMAC, KSS) and knee range of motion (ROM).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Compared to non-diabetics, patients with diabetes were more likely to possess a higher BMI (p-value &lt;0.001), more comorbidities (p-value &lt;0.001) and poorer preoperative SF-36 PCS (p-value &lt;0.001), WOMAC (p-value=0.002), KSS-Function (p-value &lt;0.001) and knee ROM (p-value &lt;0.001). Multiple regression showed that diabetic patients experienced marginally poorer improvements in KSS-Knee (-1.22 points, p-value=0.025) and knee ROM (-1.67°, p-value=0.013) compared to non-diabetics. However, there were no significant differences in improvements for SF-36 PCS (p-value=0.163), MCS (p-value=0.954), WOMAC (p-value=0.815) and KSS-Function (p-value=0.866).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>Patients with well-controlled diabetes (HbA1c &lt;8.0%) can expect similar improvements in general-health and osteoarthritis outcomes (SF-36 PCS/MCS, WOMAC and KSS-Function) compared to non-diabetics after TKA. Despite having marginally poorer improvements in knee-specific outcomes (KSS-Knee and knee ROM), these differences are unlikely to be clinically significant.</p>
orthopedics
What problem does this paper attempt to address?